報到

Welcome Remarks

澳洲駐台代表 馮國斌先生

Opening Remarks

吳忠勳 博士 / 台灣生物產業發展協會 理事長

專題演講：
澳洲 – 生技研究及創新大國

Helen Dai, Trade and Investment Commissioner, Australia Trade and Investment

合照留念

綜合座談：
澳洲卓越臨床試驗產業發展現況

主持人:

• David Lloyd, Managing Director, Southern Star Research

與談人:

• Yvonne Lungershausen, CEO, Avance
• John Lin, Taiwan Country Manager, George Clinical
• Yooni Kim, Vice President, Global Head of Clinical Trials Service, Novotech
• Robert Lin, CEO, GreenLight Clinical
• Ya-Han Chang, Vice President Commercial Strategy, HiRO

綜合座談: 
澳洲一流的臨床試驗設施的實務經驗分享 

主持人: 

• Yvonne Lungershausen, CEO, Avance

與談人:

• Chris Saracini, Business Development Officer, CMAX
• Jeffery Wong, Senior Director, Nucleus Network
• Chris Stellatos, Director, Scientia Clinical Research
• Tam C. Nguyen, Deputy Director of Research, St. Vincent’s Hospital (Melbourne)

中場休息

澳洲臨床試驗成功案例分享

綜合座談:
澳洲高效率的臨床試驗解析

主持人: 

• Tam C. Nguyen, Deputy Director of Research, St. Vincent Hospital

與談人：

• Sharon Sim, Senior Business Development Manager, 360biolabs
• Amelia Wee, Senior Business Development Manager, Agilex Biolabs
• Clara Ya, Business Development Executive, PCI
• Minh-Thu Cao Xuan, Business Development Manager, TrialKey

綜合座談:
澳洲政府研發獎勵補助的攻略

主持人: 

• Jeffery Wong, Senir Director, Nucleus Network

與談人:

• Luis Silva, Regional Business Development Manager, Acclime Australia
• Pavel Reddy, R&D Tax Advisor, Global R&D

綜合座談:
台澳創新療法的發展與契機

主持人: 

• Michael Huang, Director, BPIPO & Vice President, Innovation and Entrepreneur Core, DCB

與談人：

• Afsar Ahmed, Chief Scientific Officer, Aeterna
• Andrea Wang, CEO, AHEAD Medicine Corporation
• Yi-Lun Chiang, Business Development Manager, BRIM Biotechnology Inc
• Patty Sung, President & COO, Intelligene
• Authur Lung, CEO, NaviFUS Corp

上午場結束

午餐

一對一會談

Registration

Opening Remarks

• Simon Wang, President & CEO, Taiwan External Trade Development Council
• Wallace Lin, Secretary General, Taiwan Bio Industry Organization

BIO Asia Awards-Successful Stories

Development and Applications of Gen AI in Clinical Researc

Tong Guo,
Vice President, Head of Sales, Greater China, IQVIA

Break

Regional Collaboration Summit-Partnership, Collaboration & Synerg

• Helen Dai, Trade and Investment Commissioner, Australia Trade and Investment Commission (Austrade)
• Els Verhulst, Science & Technology Counselor, FLANDERS INVESTMENT & TRADE, Embassy of Belgium in Tokyo, Japan
• Cheung Hoi (Albert) Yu, Chairman, Hong Kong Biotechnology Organization
• Yoshiaki Tsukamoto, Executive Director, Japan Bioindustry Association
• Bryan See, the Vice President of PhytoGaia Sdn. Bhd.
• Nares Damrongchai, Co-Founder, Accel Group Co., Ltd.
• Murali Panchapagesa Muthuswamy, Chairman, Jananom Private Limited

Cultivate Business Growth by Listing on TWSE

Peter CHNG, Assistant Manager, Taiwan Stock Exchange 

Closing

Registration and networking

Opening Presentation:
Belgium – The Health & Biotech Valley, In the heart of Europe 
Today and Tomorrow

Mr. Matthieu Branders, Director of Belgian Office Taipei

Flanders Life Sciences - A Thriving Combination of Biotech and Pharma

Speaker:
Mrs. Els Verhulst, Science & Technology Counselor
FLANDERS INVESTMENT & TRADE, Embassy of Belgium in Tokyo, Japan

Biocovergence: how the intersection of biology and technology advance human health 

Speaker:
Paru Deshpande, Vice President R&D, Health Technologies, Imec vzw

IBA’s Proton Therapy and Pharma Solutions

Speaker:
Mr. Florian Vanlangendonck,
Technical Operations Leader, IBA

Revolutionizing the diagnosis and monitoring of diseases by advancing the science of epigenetics - Volition’s nucleosome quantification technology (Nu.Q®)
 

Speaker:
Dr. Jasmine Kway, CEO Volition Asia

Q&A and Networking time

Opening Remarks 

Prof. Yoshiaki Tsukamoto
Session Chair; Executive Director, Japan Bioindustry Association

Opening Remarks 

Dr. Michael Huang
Director of Biotechnology and Pharmaceutical Industries Promotion
Office, Ministry of Economic Affairs, Taiwan

Bioecosystem in Japan

Prof. Yoshiaki Tsukamoto
Session Chair; Executive Director, Japan Bioindustry Association

Takeda’s Partnering Strategy to Access Emerging Innovations across Asia-Pacific

Masanori Sato
Head, Center for External Innovation Japan/APAC,
Takeda Pharmaceutical Company Limited

Business expansion at AGC Biologics and collaboration with partners

Shigeru Kunii
Head of Business Development, Asia, AGC Biologics

Partners For Life, Expansion of FUJIFILM's Lifesciences Business in Asia

Takeshi Yamamoto
Corporate Vice president. Deputy General Manager, Lifescience
strategy HQ. General Manager, Bioscience & Engineering laboratories, FUJIFILM

Latest Topics in Japanese life Science Innovation Ecosystem

Prof. Akihiko Soyama
CEO, Life Science Innovation Network Japan

Panel Discussion

Moderator:

• Prof. Yoshiaki Tsukamoto, Executive Director, Japan Bioindustry Association

Panelists:

• Dr. Michael Huang, Director of Biotechnology and Pharmaceutical​ Industries Promotion Office, Ministry Of Economic Affairs, Taiwan
• Masanori Sato, Head, Center for External Innovation Japan/APAC,Takeda Pharmaceutical Company Limited
• Shigeru Kunii, Senior Director, Head of Business Development, Asia, AGC Biologics
• Takeshi Yamamoto, Corporate vice president. Deputy GeneralManager, Lifescience strategy HQ. General Manager, Bioscience &Engineering laboratories, FUJIFILM
• Prof. Akihiko Soyama, CEO, Life Science Innovation Network Japan

Opening Remarks 

Dr. Shiing-Jer Twu
Chairman, Development Center for Biotechnology

Opening Remarks 

Mr. Narong Boonsatheanwong
Executive Director, Thailand Trade and Economic Office

Delivering Essential Medicine and Vaccine Via Transdermal

Mr. Veerachat Petpisit, MD
CEO, Mineed Technology Co., Ltd, Thailand

Perspective of Precision Health and Next Generation Probiotics

Dr.Cheng-Chih (Richard) Hsu
CEO, Leeuwenhoek Laboratories Co. Ltd.  

Introduction of SciVision Biotech

Ms. Janet Wang
Business Development Representative, SciVision Biotech Inc.

Advancing Healthcare: Precision and Preventive Solutions by MP Group

Ms. Phansa Phitthayaphong,
Product Manager, MP Group (Thailand) Co. Ltd.

Accelerated computing platform empowering healthcare providers to accelerate healthcare transformation with multi-omics technologies, bridging the gaps in diagnostic demands throughout patient journey

Allen Chang
CEO & EVP of Business Development, Atgenomix

Entering the Cancer Arena: The Birth of  Avatar Medicine

Mr. Po Chen,
Founder & CEO, CancerFree Biotech, Taiwan

Panel Discussion or Conclusion

Moderator: 

• Dr. Nares Damrongchai, Co-Founder, Accel Group Co., Ltd.

Panelists:

• Mr. Veerachat Petpisit, MD, CEO, Mineed Technology Co., Ltd, Thailand
• Ms. Phansa Phitthayaphong
  Product Manager, MP Group (Thailand) Co. Ltd.
• Dr.Cheng-Chih (Richard) Hsu, CEO, Leeuwenhoek Laboratories Co. Ltd.
• Allen Chang, CEO & EVP of Business Development, Atgenomix
• Mr. Po Chen, Founder & CEO, CancerFree Biotech, Taiwan
• Ms. Janet Wang, Business Development Representative, SciVision Biotech Inc.

Registration

Opening Remarks

Manharsinh L. Yadav
Director General, India Taipei Association

Introduction of India Biotech Ecosystem

Murali Panchapagesa Muthuswamy
Chairman, Jananom Private Limited

India's Pharmaceutical Prowess on the Global Stage

Representative from Dr. Reddy’s Laboratory

India-Taiwan Collaboration and Potential in Pharmaceutical Industry

Kumar Surupa, Business Development Manager, Gongwin Biopharm Co., Ltd.

Conclusion

Registration

Welcoming Remarks

Madam Aznifah Isnariah Abdul Ghani
President
Malaysian Friendship and Trade Centre (MFTC)

Appreciation to speakers & group photo

Futuristic 5G Biotic: Innovation in Postbiotic Production

Gems from the Rainforest: Modern Approach to Healthy Ageing through Patented and Clinically Validated Herbs 

Mdm. Haliza Binti Ramli, Acting Chief Executive Officer, Biotropics Malaysia Berhad

Revolutionising OMICs　Data for Global Disease Management via AI/ML

Mr. Fadzhairi Jabar, Chief Executive Officer, Arcadia Life Sciences Sdn Bhd

Tocotrienols – Safeguarding of Cognitive Health and Brain Vitality

Mr. Bryan See, Vice President , PhytoGaia Sdn Bhd

Taiwan-Malaysia: Opportunities for Pharmaceutical Industry Linkage and Business Collaboration

Mdm. Patty Wang
Acting General Manager, Medical & Pharmaceutical Industry Technology & Development Centre, Taiwan

Q&A session

End of program / Networking session